Quick Takeaways
- Casdin Capital, LLC filed SCHEDULE 13G/A for Century Therapeutics, Inc. Common Stock, $0.0001 par value per share (IPSC).
- Disclosed ownership: 3.7%.
- Date of event: 31 Mar 2025.
Casdin Capital, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Century Therapeutics, Inc. Common Stock, $0.0001 par value per share (IPSC)
- Filing Manager
- Casdin Capital, LLC
- Reporting Manager
- Casdin Capital, LLC
- Symbol
- IPSC
- Shares outstanding
- 86,819,351 shares
- Disclosed Ownership
- 3,212,316 shares
- Ownership
- 3.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 16:27:17 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Casdin Capital, LLC disclosed 3.7% ownership in Century Therapeutics, Inc. Common Stock, $0.0001 par value per share (IPSC) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 16:27.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Casdin Capital, LLC | 3.7% | 3,212,316 | 0 | 3,212,316 | /s/ Eli Casdin | Eli Casdin / Managing Member | |
| Eli Casdin | 3.7% | 3,212,316 | 0 | 3,212,316 | /s/ Eli Casdin | Eli Casdin |